Stein Steven H — SEC insider filings

SEC reporting owner CIK 1673776. 45 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 45 filings on record, filed 2020-11-18 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
INCYTE CORP (INCY)CMO & Head of Late-Stage Dev.39—20 legs · 418,102 sh · $43,728,85790
Theseus Pharmaceuticals, Inc. (THRX)Director3——4
Kura Oncology, Inc. (KURA)Director2——2
Repare Therapeutics Inc. (RPTX)Director1——1

Insider filings — Stein Steven H

FiledFormIssuerReported transactionsSource
2026-11-184INCYTE CORP (INCY)Option exercise (M): 576 @ $68.25 · Sale (S): 576 @ $121.98 · Option exercise (M): 576 (derivative) @ $0EDGAR
2026-11-104INCYTE CORP (INCY)Option exercise (M): 8,539 @ $68.62 · Option exercise (M): 12,335 @ $72.27 · Option exercise (M): 16,428 @ $80.50 · Option exercise (M): 15,054 @ $74.78 · Option exercise (M): 23,526 @ $77.67 · Option exercise (M): 18,331 @ $61.76 · +31 moreEDGAR
2026-07-204INCYTE CORP (INCY)Sale (S): 1,877 @ $114.73 · Grant/award (A): 9,798 @ $0 · Grant/award (A): 24,496 (derivative) @ $0 · Grant/award (A): 42,298 (derivative) @ $0EDGAR
2026-07-164INCYTE CORP (INCY)Tax withholding (F): 21,830 @ $114.88 · Sale (S): 28,237 @ $113.05 · Tax withholding (F): 3,088 @ $115.09EDGAR
2026-07-074INCYTE CORP (INCY)Tax withholding (F): 2,177 @ $116.86EDGAR
2026-05-204/AINCYTE CORP (INCY)Grant/award (A): 44,124 @ $0EDGAR
2026-04-174INCYTE CORP (INCY)Grant/award (A): 39,049 @ $0EDGAR
2026-01-214INCYTE CORP (INCY)Grant/award (A): 19,932 (derivative) @ $0EDGAR
2026-01-074INCYTE CORP (INCY)Sale (S): 15,634 @ $101.70EDGAR
2026-01-054INCYTE CORP (INCY)Tax withholding (F): 13,292 @ $98.77EDGAR
2025-12-034INCYTE CORP (INCY)Sale (S): 2,559 @ $102.96 · Tax withholding (F): 17,093 @ $102.04 · Sale (S): 20,105 @ $102.51EDGAR
2025-11-074INCYTE CORP (INCY)Option exercise (M): 1,194 @ $83.83 · Option exercise (M): 2,995 @ $95.76 · Option exercise (M): 1,044 @ $95.76 · Sale (S): 5,233 @ $102.20 · Option exercise (M): 1,194 (derivative) @ $0 · Option exercise (M): 2,995 (derivative) @ $0 · +1 moreEDGAR
2025-07-234INCYTE CORP (INCY)Sale (S): 3,706 @ $67.94EDGAR
2025-07-164INCYTE CORP (INCY)Sale (S): 14,952 @ $68.47 · Tax withholding (F): 1,555 @ $69.98 · Tax withholding (F): 1,596 @ $68.25 · Grant/award (A): 12,277 @ $0 · Grant/award (A): 30,692 (derivative) @ $0 · Grant/award (A): 27,629 (derivative) @ $0EDGAR
2025-07-074INCYTE CORP (INCY)Tax withholding (F): 12,714 @ $68.17EDGAR
2025-04-034INCYTE CORP (INCY)Grant/award (A): 37,198 @ $0 · Grant/award (A): 20,967 @ $0EDGAR
2025-01-224INCYTE CORP (INCY)Sale (S): 12,352 @ $72.69 · Grant/award (A): 28,202 (derivative) @ $0EDGAR
2025-01-174INCYTE CORP (INCY)Tax withholding (F): 10,692 @ $72.46EDGAR
2024-08-144INCYTE CORP (INCY)Sale (S): 11,608 @ $60.63EDGAR
2024-07-174INCYTE CORP (INCY)Grant/award (A): 13,895 @ $0 · Tax withholding (F): 1,555 @ $64.25 · Grant/award (A): 31,088 (derivative) @ $0EDGAR
2024-07-034INCYTE CORP (INCY)Tax withholding (F): 8,316 @ $59.02EDGAR
2024-06-204Repare Therapeutics Inc. (RPTX)Grant/award (A): 54,000 (derivative) @ $0EDGAR
2024-02-164INCYTE CORP (INCY)Grant/award (A): 7,377 @ $0EDGAR
2024-02-144Theseus Pharmaceuticals, Inc. (THRX)Disposition to issuer (D): 3,250 (derivative)EDGAR
2024-01-224INCYTE CORP (INCY)Grant/award (A): 30,580 (derivative) @ $0EDGAR
2024-01-054INCYTE CORP (INCY)Sale (S): 7,365 @ $65.51EDGAR
2023-08-034INCYTE CORP (INCY)Sale (S): 21,511 @ $63.28EDGAR
2023-07-184INCYTE CORP (INCY)Grant/award (A): 13,535 @ $0 · Grant/award (A): 28,385 (derivative) @ $0EDGAR
2023-07-064INCYTE CORP (INCY)Tax withholding (F): 8,442 @ $62.08EDGAR
2023-06-134Theseus Pharmaceuticals, Inc. (THRX)Grant/award (A): 19,500 (derivative) @ $0 · Grant/award (A): 3,250 (derivative) @ $0EDGAR
2023-01-244INCYTE CORP (INCY)Grant/award (A): 4,980 @ $0 · Grant/award (A): 27,096 (derivative) @ $0EDGAR
2023-01-064INCYTE CORP (INCY)Sale (S): 28,399 @ $79.78EDGAR
2022-10-194Theseus Pharmaceuticals, Inc. (THRX)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2022-07-064INCYTE CORP (INCY)Grant/award (A): 18,941 @ $0 · Tax withholding (F): 3,856 @ $79.25 · Grant/award (A): 25,665 (derivative) @ $0EDGAR
2022-06-304INCYTE CORP (INCY)Tax withholding (F): 11,488 @ $75.63EDGAR
2022-06-234Kura Oncology, Inc. (KURA)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2022-01-214INCYTE CORP (INCY)Grant/award (A): 15,054 (derivative) @ $0EDGAR
2022-01-054INCYTE CORP (INCY)Grant/award (A): 28,926 @ $0EDGAR
2021-11-234INCYTE CORP (INCY)Grant/award (A): 379 @ $0 · Grant/award (A): 2,355 @ $0EDGAR
2021-07-074INCYTE CORP (INCY)Grant/award (A): 7,853 @ $0 · Tax withholding (F): 2,953 @ $83.58 · Tax withholding (F): 402 @ $83.34 · Grant/award (A): 15,054 (derivative) @ $0EDGAR
2021-06-304INCYTE CORP (INCY)Tax withholding (F): 22,079 @ $85.61EDGAR
2021-06-234Kura Oncology, Inc. (KURA)Grant/award (A): 23,000 (derivative) @ $0EDGAR
2021-01-274INCYTE CORP (INCY)Option exercise (M): 3,795 @ $68.62 · Sale (S): 3,795 @ $100 · Option exercise (M): 3,795 (derivative) @ $0EDGAR
2021-01-204INCYTE CORP (INCY)Grant/award (A): 23,044 @ $0 · Grant/award (A): 12,743 (derivative) @ $0EDGAR
2020-11-184INCYTE CORP (INCY)Grant/award (A): 1,232 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1673776 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs